Literature DB >> 20510746

HIV-2 capsids distinguish high and low virus load patients in a West African community cohort.

Clayton O Onyango1, Aleksandra Leligdowicz, Masaru Yokoyama, Hironori Sato, Haihan Song, Emi E Nakayama, Tatsuo Shioda, Thushan de Silva, John Townend, Assan Jaye, Hilton Whittle, Sarah Rowland-Jones, Matthew Cotten.   

Abstract

HIV-2 causes AIDS similar to HIV-1, however a considerable proportion of HIV-2 infected patients show no disease and have low plasma virus load (VL). An analysis of HIV-2 capsid (p26) variation demonstrated that proline at p26 positions 119, 159 and 178 are more frequent in lower VL subjects while non-proline residues at all three sites are more frequent in subjects with high VL. In vitro replication levels of viruses bearing changes at the three sites suggested that these three residues influence virus replication by altering susceptibility to TRIM5alpha. These results provide new insights into HIV-2 pathogenesis. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20510746     DOI: 10.1016/j.vaccine.2009.08.060

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  22 in total

1.  A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV.

Authors:  Molly OhAinle; Louisa Helms; Jolien Vermeire; Ferdinand Roesch; Daryl Humes; Ryan Basom; Jeffrey J Delrow; Julie Overbaugh; Michael Emerman
Journal:  Elife       Date:  2018-12-06       Impact factor: 8.140

2.  Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.

Authors:  Louis-Marie Yindom; Aleksandra Leligdowicz; Maureen P Martin; Xiaojiang Gao; Ying Qi; Syed M A Zaman; Maarten Schim van der Loeff; Carla van Tienen; Assan Jaye; Akum Aveika; Archibald Worwui; Mathurin Diatta; Tim Vincent; Hilton C Whittle; Sarah L Rowland-Jones; Robert Walton; Mary Carrington
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

3.  Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village.

Authors:  Maarten F Schim van der Loeff; Natasha Larke; Steve Kaye; Neil Berry; Koya Ariyoshi; Abraham Alabi; Carla van Tienen; Aleksandra Leligdowicz; Ramu Sarge-Njie; Zacharias da Silva; Assan Jaye; Dominique Ricard; Tim Vincent; Sarah Rowland Jones; Peter Aaby; Shabbar Jaffar; Hilton Whittle
Journal:  Retrovirology       Date:  2010-05-19       Impact factor: 4.602

4.  Multiple sites in the N-terminal half of simian immunodeficiency virus capsid protein contribute to evasion from rhesus monkey TRIM5α-mediated restriction.

Authors:  Ken Kono; Haihan Song; Masaru Yokoyama; Hironori Sato; Tatsuo Shioda; Emi E Nakayama
Journal:  Retrovirology       Date:  2010-09-08       Impact factor: 4.602

Review 5.  Delayed disease progression in HIV-2: the importance of TRIM5α and the retroviral capsid.

Authors:  M T Boswell; S L Rowland-Jones
Journal:  Clin Exp Immunol       Date:  2019-03-21       Impact factor: 4.330

6.  Potent autologous and heterologous neutralizing antibody responses occur in HIV-2 infection across a broad range of infection outcomes.

Authors:  Thushan I de Silva; Marlén Aasa-Chapman; Matthew Cotten; Stéphane Hué; James Robinson; Frederic Bibollet-Ruche; Ramu Sarge-Njie; Neil Berry; Assan Jaye; Peter Aaby; Hilton Whittle; Sarah Rowland-Jones; Robin Weiss
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

7.  The carboxyl-terminus of human immunodeficiency virus type 2 circulating recombinant form 01_AB capsid protein affects sensitivity to human TRIM5α.

Authors:  Tadashi Miyamoto; Emi E Nakayama; Masaru Yokoyama; Shiro Ibe; Shunpei Takehara; Ken Kono; Yoshiyuki Yokomaku; Massimo Pizzato; Jeremy Luban; Wataru Sugiura; Hironori Sato; Tatsuo Shioda
Journal:  PLoS One       Date:  2012-10-19       Impact factor: 3.240

8.  Molecular dynamics simulation in virus research.

Authors:  Hirotaka Ode; Masaaki Nakashima; Shingo Kitamura; Wataru Sugiura; Hironori Sato
Journal:  Front Microbiol       Date:  2012-07-19       Impact factor: 5.640

9.  Gain-of-sensitivity mutations in a Trim5-resistant primary isolate of pathogenic SIV identify two independent conserved determinants of Trim5α specificity.

Authors:  Kevin R McCarthy; Aaron G Schmidt; Andrea Kirmaier; Allison L Wyand; Ruchi M Newman; Welkin E Johnson
Journal:  PLoS Pathog       Date:  2013-05-09       Impact factor: 6.823

10.  High level of susceptibility to human TRIM5α conferred by HIV-2 capsid sequences.

Authors:  Junko S Takeuchi; Benjamin Perche; Julie Migraine; Séverine Mercier-Delarue; Diane Ponscarme; François Simon; François Clavel; Béatrice Labrosse
Journal:  Retrovirology       Date:  2013-05-06       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.